A new study from Euroimmun, published in PLoS Neglected Tropical Diseases, demonstrates how customised testing for different dengue serological markers can improve diagnostic accuracy across different stages of infection. Diagnostic challenges Accurate diagnosis of dengue virus (DENV) infection is challenging due to its non-specific early symptoms and potential for rapid clinical deterioration. While RT-PCR is […]
Notification EUROIMMUN AG from Lübeck in Germany, a manufacturer of reagents and automated systems for medical laboratory diagnostics, has developed a PCR test for direct virus detection, in addition to the assays for the detection of antibodies against SARS-CoV-2 (ELISA). The new test is a real-time reverse transcriptase PCR used to detect the genetic material
Press release EUROIMMUN AG (Lübeck, Germany), a manufacturer of reagents and instruments for medical laboratory diagnostics, has developed serological tests for detection of antibodies against the novel coronavirus SARS-CoV-2. The two ELISAs enable detection of specific IgA and IgG against the virus in the blood of infected patients. In December 2019 the WHO in China
It all started at a market in Wuhan, China. Within a few weeks, a novel coronavirus, now called 2019-nCoV, spread to at least 15 regions or countries outside of the Chinese mainland. In December 2019, the WHO China Country Office was informed of cases of pneumonia of unknown aetiology (unknown cause) detected in Wuhan City,
This autumn, cases of West Nile virus and Zika virus infections due to transmission by infected mosquitoes have occurred locally for the first time in Germany and France. These cases of locally acquired infections are also named autochthonous cases. Several infectious agents, some of them just newly identified, have spread globally over the past years,
